Search

Search Constraints

You searched for: Author/Creator Marzinke, Mark A.

Search Results

31. Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial. (1st November 2015)

32. Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects. Issue 10 (4th July 2022)

34. Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation. (2nd January 2016)

35. Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention. (July 2018)

36. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates (Adv. Therap. 3/2021). Issue 3 (23rd March 2021)

37. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates. Issue 3 (16th December 2020)

38. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. Issue 2 (February 2021)

39. Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis. (24th August 2018)

40. Tenofovir-Based Preexposure Prophylaxis for HIV Infection Among African Women. Issue 7 (July 2015)